Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
RaQualia Pharma
Market Cap: JP¥7.3b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥334.00
7D
11.0%
1Y
-45.1%
Nxera Pharma
Market Cap: JP¥66.5b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥740.00
7D
6.3%
1Y
-51.1%